Get the weekly note
ETFIQetfiq.com · independent ETF data

Data as of .

ABOT vs LFSC: which is really different?

ABOT and LFSC hold 1% of their weight in the same names, and LFSC returned more over the year.

Abacus FCF Innovation Leaders ETF and F/m Emerald Life Sciences Innovation ETF.

70.2%ABOT in the S&P 500
0.0%LFSC in the S&P 500
+7.7%ABOT total return, 1 year
+53.0%LFSC total return, 1 year

ETFIQ Off-Index Score: LFSC scores higher

How much of it is not the index it is sold as an alternative to?

ABOT 11.6LFSC 91.80.1, the lowest in this set91.8, the highest

A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed

ABOT30% of its weight is outside the S&P 500 · 1 year to Sep 18, 2026
70%30%of its weight in S&P 500 companiesoutside the S&P 500active share 81% · top ten 37% of the fund · 54 holdings filed Apr 30, 2026 · Nasdaq-100: 47% in70%30%in the S&P 500outsideactive share 81% · top ten 37% of the fund
LFSC100% of its weight is outside the S&P 500 · 1 year to Sep 18, 2026
0%100%0% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 100% · top ten 55% of the fund · 39 holdings filed May 31, 2026 · Nasdaq-100: 1% in0%100%0% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 100% · top ten 55% of the fund

1% of the two portfolios are the same securities at the same weight.

What they hold in common

By the books each fund has filed, ABOT and LFSC hold 1% of their money in the same securities at the same weight.

Positions ABOT and LFSC both hold, largest shared weight first
HoldingABOTLFSC
Corcept Therapeutics Inc0.66%4.79%
Only in each
Only in ABOTOnly in LFSC
NVIDIA Corp 6.32%Travere Therapeutics Inc 7.66%
Apple Inc 5.46%Cogent Biosciences Inc 7.52%
Broadcom Inc 4.61%LivaNova PLC 7.11%
Bristol-Myers Squibb Co 3.21%Spyre Therapeutics Inc 6.41%
QUALCOMM Inc 3.18%Guardant Health Inc 5.51%
Airbnb Inc 3.06%Mirum Pharmaceuticals Inc 4.92%
VeriSign Inc 2.88%United Therapeutics Corp 4.15%
AbbVie Inc 2.85%VeraDermics Inc 3.42%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and May 31, 2026.

Performance, window by window

ABOT and LFSC over each window. Every figure is an ETFIQ calculation with distributions reinvested. Source: ETFIQ.
WindowTotal returnvs the S&P 500vs the Nasdaq-100
ABOTLFSCABOTLFSCABOTLFSC
3 months+15.7%+8.7%+13.4 pts+6.5 pts+18.2 pts+11.2 pts
6 months+30.5%+36.0%+12.4 pts+17.9 pts+6.2 pts+11.7 pts
1 year+7.7%+53.0%−8.9 pts+36.5 pts−14.1 pts+31.3 pts
3 years+76.5%not published−1.9 ptsnot published−21.6 ptsnot published
Since launch+88.3%+81.3%−34.9 pts+44.3 pts−53.9 pts+30.9 pts
Open the live comparison on ETFIQ
ABOT and LFSC on the same fields, as of Sep 18, 2026. Source: ETFIQ.
ABOT
Abacus FCF Innovation Leaders ETF
Holds 54 stocks in broad innovation and megatrends, 70% of its weight in S&P 500 companies
LFSC
F/m Emerald Life Sciences Innovation ETF
Holds 39 stocks in broad innovation and megatrends, 0% of its weight in S&P 500 companies
IssuerAbacus FCFF/m
ThemeBroad innovation and megatrendsBroad innovation and megatrends
In the S&P 50070.2%0.0%
Active share vs the S&P 50080.9%100.0%
In the Nasdaq-10046.5%0.6%
Holdings5439
Top ten, share of the fund36.5%54.7%
Expense ratio0.39%0.54%
Fee for the differing part0.48%0.54%
Total return, 1 year+7.7%+53.0%
vs the S&P 500−8.9 pts+36.5 pts
vs the Nasdaq-100−14.1 pts+31.3 pts
Below its high−2.4%−6.8%
Net assets$4m$105m

ABOT in plain words

By weight, 70% of ABOT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 81%. The top ten holdings are 36% of the fund across 54 positions, as filed for Apr 30, 2026. Over the year to Sep 18, 2026 the fund returned +7.7% with distributions reinvested against +16.6% for the S&P 500, so a holder was behind by 8.9 pts.

LFSC in plain words

By weight, 0% of LFSC's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 55% of the fund across 39 positions, as filed for May 31, 2026. Over the year to Sep 18, 2026 the fund returned +53.0% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 36.5 pts. It sits 6.8% below its all-time high of Aug 19, 2026.

Questions people ask

Do ABOT and LFSC hold the same stocks?
By their latest filings, 1% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, ABOT or LFSC?
ABOT has 70% of its weight in S&P 500 names and LFSC has 0%, so LFSC differs more from the index.
Which is cheaper, ABOT or LFSC?
ABOT charges 0.39% a year and LFSC charges 0.54%, so ABOT is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

ABOT against LFSC, ETFIQ, data as of Sep 18, 2026. Every figure is calculated from a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, ABOT against LFSC, data as of Sep 18, 2026. https://etfiq.com/compare/themes/abot-vs-lfsc Free to use with attribution; the underlying files are at Open data.

How every figure is computed · Standards and sources